Figure 2From: Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patientsDexmedetomidine concentration profiles of the 13 patients during the infusion and the 48-hour follow-up. The 48-hour follow-up was not reached in the three patients who were withdrawn from the study treatment and died of adverse events. Conc, concentration.Back to article page